A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells

被引：28

作者：

Kanamori, Y

Kigawa, J

Minagawa, Y

Irie, T

Oishi, T

Shimada, M

Takahashi, M

Nakamura, T

Sato, K

Terakawa, N

机构：

[1] Tottori Univ, Sch Med, Dept Obstet & Gynaecol, Yonago, Tottori 683, Japan

[2] Tottori Univ, Sch Med, Dept Biol Mol, Yonago, Tottori 683, Japan

来源：

EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 11期

关键词：

ovarian cancer; CDDP; p53 gene transfer; recombinant adenovirus;

D O I：

10.1016/S0959-8049(98)00199-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A new recombinant adenovirus carrying a wild-type p53 gene (AxCAp53) was developed and the combination effect of p53 gene transfer and cis-diamminedichloroplatinum (II) (CDDP) was examined in an ovarian cancer cell line, SK-OV-3, with deletion of the p53 gene. AxCAp53 showed a high efficiency of gene transduction and increased sensitivity to CDDP in the SK-OV-3 cells. It was found that the sensitivity of the cells to CDDP correlated with the amount of infectious units of virus per cell of AxCAp53 which correlated with p53 protein expression. The results suggest that the combination of CDDP and AxCAp53 may be a potential strategy for the therapy of CDDP-resistant ovarian cancer. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：1802 / 1806

页数：5

共 50 条

[41] Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent
Ogawa, N
Fujiwara, T
Kagawa, S
Nishizaki, M
Morimoto, Y
Tanida, T
Hizuta, A
Yasuda, T
Roth, JA
Tanaka, N
INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (03) : 367 - 370
[42] A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
Schuler, M
Rochlitz, C
Horowitz, JA
Schlegel, J
Perruchoud, AP
Kommoss, F
Bolliger, CT
Kauczor, HU
Dalquen, P
Fritz, MA
Swanson, S
Herrmann, R
Huber, C
HUMAN GENE THERAPY, 1998, 9 (14) : 2075 - 2082
[43] Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer
Bouvet, M
Bold, RJ
Lee, J
Evans, DB
Abbruzzese, JL
Chiao, PJ
McConkey, DJ
Chandra, J
Chada, S
Fang, BL
Roth, JA
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (08) : 681 - 688
[44] Effects of wild-type p53 gene on the chemotherapy sensitivity of ovarian cancer SKOV-3 cells to cisplatin
Jin, Zhen
Guan, Ting
Li, Shourou
Chinese Journal of Medical Genetics, 2002, 19 (03) : 218 - 220
[45] ADENOVIRUS-MEDIATED WILD-TYPE P53 EXPRESSION INDUCES APOPTOSIS AND SUPPRESSES TUMORIGENESIS OF PROSTATIC TUMOR-CELLS
YANG, CL
CIRIELLI, C
CAPOGROSSI, MC
PASSANITI, A
CANCER RESEARCH, 1995, 55 (19) : 4210 - 4213
[46] Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells
Katayose, D
Gudas, J
Nguyen, H
Srivastava, S
Cowan, KH
Seth, P
CLINICAL CANCER RESEARCH, 1995, 1 (08) : 889 - 897
[47] Adenovirus-mediated p53 gene transfer to rat testis impairs spermatogenesis
Fujisawa, M
Shirakawa, T
Fujioka, H
Gotoh, A
Okada, H
Arakawa, S
Kamidono, S
ARCHIVES OF ANDROLOGY, 2001, 46 (03): : 223 - 231
[48] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
A Vinyals
M A Peinado
M Gonzalez-Garrigues
M Monzó
R D Bonfil
A Fabra
Gene Therapy, 1999, 6 : 22 - 33
[49] Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts
Kawabe, S
Munshi, A
Zumstein, LA
Wilson, DR
Roth, JA
Meyn, RE
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2001, 77 (02) : 185 - 194
[50] Establishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cells
Chi, Tian-Yi
Chen, George G.
Ho, Lok-Kee
Lai, Paul B. S.
CANCER CELL INTERNATIONAL, 2005, 5 (1)

← 1 2 3 4 5 →